For example, JAK inhibitors may be more effective than TNF antagonists in controlling disease in patients with ulcerative colitis, leading to lower rates of corticosteroid use.55,56 This finding may explain the lower risk of serious infections with JAK inhibitors vs TNF antagonists in patients with IBD. This evidence concerns the gene TNF and inflammatory bowel disease.